In addition, the treatment of Rho kinase inhibitor Y-27632 suppressed IgG leakage in Akap12 knockout stroke mice (Figure 5c–e), which was consistent with our in vitro findings that the activation of Rho signaling pathway causes endothelial leakiness under the conditions of AKAP12 downregulation. This evidence concerns the gene AKAP12 and stroke disorder.